RBCGX Performance — Reynolds Blue Chip Growth Fund, N/a Class
Data updated: 2026-08-21
RBCGX returned +3.00% year to date and +7.58% over one year to Jun 2026. Annualised returns are +19.52% over 3 years and +8.62% over 5 years. Against its Alternative category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $171, against $170 for the category, and to $108 over one year, against $110. Volatility over the past three years was 16.77% a year. In the 12 months to Jun 2026 the fund took in a net $619K, and assets reached $69.69M.
RBCGX Growth of $100
What $100 invested in Reynolds Blue Chip Growth Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | RBCGX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $108 | $110 |
| 3 years (Jul 2023 – Jun 2026) | $171 | $170 |
| 5 years (Jul 2021 – Jun 2026) | $151 | $159 |
| Since data start (Jan 2020 – Jun 2026) | $238 | $183 |
RBCGX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +3.00% |
| 1 year | +7.58% |
| 3 years (annualised) | +19.52% |
| 5 years (annualised) | +8.62% |
RBCGX Annual Returns
Calendar-year total returns of Reynolds Blue Chip Growth Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +3.00% |
| 2025 | +14.43% |
| 2024 | +33.78% |
| 2023 | +28.80% |
| 2022 | −30.08% |
| 2021 | +16.49% |
| 2020 | +43.88% |
RBCGX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.4% | −3.3% | −3.4% | +9.6% | +5.6% | −4.3% | — | — | — | — | — | — |
| 2025 | +4.2% | −3.1% | −6.4% | +0.1% | +7.8% | +7.4% | +2.4% | +0.5% | +4.1% | +3.0% | −3.5% | −1.9% |
| 2024 | +3.7% | +7.8% | +1.5% | −5.6% | +6.5% | +7.4% | −4.8% | +2.8% | +2.8% | +1.0% | +7.7% | −0.2% |
| 2023 | +7.6% | −2.9% | +3.4% | −0.1% | +3.1% | +6.9% | +4.1% | −3.0% | −6.2% | −2.1% | +10.8% | +5.5% |
| 2022 | −8.3% | −3.8% | +2.5% | −10.3% | −2.6% | −9.1% | +9.9% | −4.6% | −6.9% | +3.3% | +4.2% | −7.2% |
| 2021 | +2.4% | +0.7% | −1.7% | +5.9% | −2.4% | +4.5% | +1.6% | +4.2% | −4.7% | +6.7% | 0.0% | −1.0% |
| 2020 | +1.6% | −6.7% | −9.9% | +13.9% | +7.1% | +5.3% | +9.1% | +13.6% | −5.6% | −3.1% | +11.5% | +3.8% |
RBCGX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 16.77%
- 3-year Sharpe ratio: 0.90 (vs 4.5% risk-free rate)
- Best month: +10.75% (Nov 2023)
- Worst month: −6.36% (Mar 2025)
RBCGX Fund Flows
Monthly money in and out of Reynolds Blue Chip Growth Fund, from SEC Form N-PORT.
- 12-month net flow: $619K
- 12-month gross sales (incl. reinvestments): $12.7M
- Sales ÷ redemptions: 1.05×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $96K | $717K | −$621K |
| May 2026 | $17K | $603K | −$585K |
| Apr 2026 | $62K | $1.0M | −$941K |
| Mar 2026 | $61K | $487K | −$426K |
| Feb 2026 | $17K | $1.0M | −$1.0M |
| Jan 2026 | $40K | $1.0M | −$999K |
| Dec 2025 | $10.4M | $1.4M | $9.0M |
| Nov 2025 | $66K | $507K | −$440K |
| Oct 2025 | $52K | $779K | −$727K |
| Sep 2025 | $535K | $1.7M | −$1.2M |
| Aug 2025 | $33K | $1.9M | −$1.8M |
| Jul 2025 | $1.3M | $1.0M | $334K |
RBCGX Assets Under Management
Net assets of Reynolds Blue Chip Growth Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $69.69M |
| 2026-03-31 | $64.90M |
| 2025-12-31 | $72.26M |
| 2025-09-30 | $76.80M |
| 2025-06-30 | $74.25M |
| 2025-03-31 | $63.46M |
| 2024-12-31 | $68.41M |
| 2024-09-30 | $64.90M |
| 2024-06-30 | $64.76M |
| 2024-03-31 | $61.57M |
| 2023-12-31 | $57.23M |
| 2023-09-30 | $52.58M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.